GlassScriptPhysician profile
Divyashree Varma
NPI 1710205000
$49,043.70
in general payments reported to CMS, 2019-2025
26 companies · $1,513 in 2025
The $1,513 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $1,192 · 2021: $1,165 · 2022: $12K · 2023: $11K · 2024: $8,181 · 2025: $1,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,617 · Travel and Lodging: $5,684 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,125 · Consulting Fee: $2,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,617.04 |
| Travel and Lodging | $5,684.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,125.00 |
| Consulting Fee | $2,850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $17,950.70 | 2020-2025 | Carto 3, Qdot Micro Catheter |
| Boston Scientific Corporation | $11,660.01 | 2019-2024 | Rhythmia Mapping System, Watchman Flx, Emblem Mri S-Icd |
| Medtronic Vascular, INC. | $9,747.50 | 2019-2020 | |
| Abbott Laboratories | $3,001.66 | 2020-2025 | Aveir, Ensite, Mitraclip |
| Medtronic, INC. | $1,892.76 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Atricure, INC. | $1,070.00 | 2022-2024 | |
| Medical Device Business Services, INC. | $993.62 | 2022 | |
| Biotronik INC. | $824.69 | 2020-2022 | |
| Baylis Medical Company INC | $458.22 | 2019 | |
| Volta Medical INC | $212.59 | 2023 | Vx1 |
| Cvrx, INC. | $185.76 | 2023-2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $147.53 | 2022 | |
| Shockwave Medical, INC | $141.87 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Altathera Pharmaceuticals LLC | $139.67 | 2023 | Sotalol Hydrochloride |
| Amgen INC. | $118.49 | 2024 | Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $94.94 | 2023 | Impella |
| Philips North America LLC | $83.88 | 2023 | |
| Penumbra, INC. | $74.23 | 2023 | Indigo System |
| Angiodynamics, INC. | $70.65 | 2022 | |
| Kestra Medical Technology Services, INC. | $46.34 | 2022-2023 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $31.59 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $27.57 | 2024 | |
| United Therapeutics Corporation | $23.34 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.92 | 2023 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Pfizer INC. | $13.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divyashree Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.